Screening compound: InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3

Screening compound: InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3
Screening compound: InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E146-1546

Molecular Formula

C19H16ClN3OS (C19 H16 ClN3 OS)

Compound Name

N-(2-chlorophenyl)-N,1-dimethyl-1H,4H-thiochromeno[4,3-c]pyrazole-3-carboxamide

IUPAC name

N-(2-chlorophenyl)-N1-dimethyl-1H4H-thiochromeno[43-c]pyrazole-3-carboxamide

SMILES

CN(C(c1nn(C)c-2c1CSc1c2cccc1)=O)c(cccc1)c1Cl

InChI

InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3

InChI Key

RRPYRNDOIZAJMK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14843242

InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

Protein-Protein Interaction Library (218420 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Nervous system
  • Immune system
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3?
Check Price and Availability of InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H16ClN3OS/c1-22(15-9-5-4-8-14(15)20)19(24)17-13-11-25-16-10-6-3-7-12(16)18(13)23(2)21-17/h3-10H,11H2,1-2H3 available by request